User Login | Create Account | Contact Us
October 11, 2019, Chicago, Illinois
Please note that slides are for review only and not to be repurposed or published.
Meet The Professors: Clinical Investigators Provide Perspectives on the Integration of Immune Checkpoint Inhibitors into the Management of Small Cell Lung Cancer
MODULE 1:Current and Future Management of Newly Diagnosed Extensive-Stage Small Cell Lung Cancer (ES-SCLC) — Dr Spigel
MODULE 2:Management of Progressive ES-SCLC — Dr Govindan
MODULE 3:Recognition and Management of Immune-Related Adverse Events with Immune Checkpoint Inhibitor Therapy in SCLC — Dr Farago
Live Poll ResultsDownload
Consensus or Controversy? Addressing Practical Clinical Questions Across the Metastatic Lung Cancer Continuum
Slide PresentationDownload